Valuation: biote Corp.

Market Cap 69.16M 60.74M 56.49M 51.83M 97.39M 6.66B 98.89M 671M 262M 3.27B 260M 254M 11.32B P/E 2026 *
9.7x
P/E 2027 * 6.33x
Enterprise Value 69.16M 60.74M 56.49M 51.83M 97.39M 6.66B 98.89M 671M 262M 3.27B 260M 254M 11.32B EV / Sales 2026 *
0.36x
EV / Sales 2027 * 0.34x
Free-Float
85.15%
Yield 2026 *
-
Yield 2027 * -
1 day+1.33%
1 week-6.17%
Current month+20.63%
1 month+8.57%
6 months+3.17%
Current year-12.31%
1 week 2.22
Extreme 2.22
2.6
1 month 1.63
Extreme 1.63
2.6
Current year 1.27
Extreme 1.27
2.68
1 year 1.27
Extreme 1.27
4.75
3 years 1.27
Extreme 1.27
8.44
5 years 1.27
Extreme 1.27
10.52
10 years 1.27
Extreme 1.27
10.52
Manager TitleAgeSince
Chief Executive Officer 49 2026-06-11
Chief Tech/Sci/R&D Officer 69 2024-02-29
Sales & Marketing - -
Director TitleAgeSince
Chairman 61 2022-04-30
Director/Board Member 51 2022-04-30
Director/Board Member 63 2022-04-30
Date Insider Type Main position Quantity % Market Cap.
6/12/26 Free

Chief Executive Officer

206,746 0.6816%
6/8/26 Free

Chief Executive Officer

130,000 0.4286%
6/8/26 Free

Chairman

114,157 0.3764%
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%-6.17%-45.19%-66.91% 68.25M
+2.27%-2.88%-21.60%+17.53% 130M
-1.14%+17.87%-35.44%-90.25% 109M
Average +0.82%+1.73%-34.08%-46.55% 102.55M
Weighted average by Cap. +0.85%+2.19%-31.74%-39.37%

Financials

2026 *2027 *
Net sales 191M 167M 156M 143M 268M 18.36B 273M 1.85B 722M 9.02B 716M 700M 31.2B 205M 180M 167M 153M 288M 19.7B 293M 1.98B 775M 9.69B 768M 751M 33.49B
Net income 8.52M 7.48M 6.96M 6.39M 12M 820M 12.18M 82.64M 32.29M 403M 31.98M 31.29M 1.39B 12.82M 11.26M 10.47M 9.61M 18.05M 1.23B 18.33M 124M 48.56M 607M 48.11M 47.07M 2.1B
Net Debt - -
Logo biote Corp.
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Employees
223
Date Price Change Volume
26-07-24 US$2.280 +1.33% 196,404
26-07-23 US$2.250 -4.26% 68,718
26-07-22 US$2.350 -6.75% 45,010
26-07-21 US$2.520 +1.20% 209,622
26-07-20 US$2.490 +2.47% 209,808
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.280USD
Average target price
2.732USD
Spread / Average Target
+19.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BTMD Stock